Enhanced Investments - Financial Portal

InMode Announces Launch of EvolveX Body Transforming Platform

Published: 2021-09-01 13:03:00 ET

IRVINE, Calif., Sept. 1, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is pleased to announce the launch of the EvolveX platform with Transform technology.

EvolveX is a hands-free, zero downtime full body transforming solution. Post-lockdown, patients continue to pursue non-invasive treatments at unprecedented levels, searching for nonsurgical alternatives to achieve toned sculpted physiques. EvolveX is the only all-in-one system equipped with clinically proven technologies to remodel skin, treat fat, and sculpt muscles. The versatility of EvolveX multi-modalities allows physicians to focus on individual patient needs by selectively or synergistically delivering procedures that produce consistent transformative results.

Moshe Mizrahy, InMode CEO, commented, "As the world begins to return to a new state of normal, the demand for hands-free, social distancing platforms continues to grow beyond our original projections. InMode's platforms provide physicians and patients with the most sought-after treatments."

"InMode's strategic mandate to deliver innovative solutions drives our robust R&D pipeline and highly successful commercialization stream. The novel Transform technology on EvolveX is another example of our unwavering commitment to provide superior, comprehensive technologies for our existing and future customers," said Shakil Lakhani, InMode North American President.

Dr. Spero Theodorou, InMode Chief Medical Officer and Plastic Surgeon commented, "EvolveX with the new Transform technology is revolutionizing non-invasive body contouring. Combined, EvolveX Tite, Tone, and Transform technologies allow for adjustable real-time procedures specific to individual patient needs. Treatments can be tailored to either selectively or simultaneously focus on loose skin, fat, and muscle."

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Press Contact:Behrman CommunicationsAmanda Reinsteinareinstein@behrmanpr.com

Investor Contact:MS-IR LLCMiri Segal – Schariair@inmodemd.comTel: 917-607-8654

View original content:https://www.prnewswire.com/news-releases/inmode-announces-launch-of-evolvex-body-transforming-platform-301366678.html

SOURCE InMode Ltd.

Enhanced Investments, Inc.
329 South Oyster Bay Road #2085
Plainview, NY 11803
team@eninvs.com

Important disclosures

Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.

Nothing on this website should be considered an offer, solicitation of an offer, or advice to buy or sell securities.
Past performance is no guarantee of future results. Any historical returns, expected returns [or probability projections] are hypothetical in nature and may not reflect actual future performance.
All the strategies assume investments in equity invstrumenta only and are more relevant for "agressive investment profile". Eastern European flagship strategy assumes using up to 20% leverage of total portfolio. GlobalCommodities and US Growth strategy currently assume no leverage.
Results for the Enhanced Investments strategies as compared to the performance of Illustrative Benchmarks is for informational purposes only. Our investment program does not mirror that of the Illustrative Benchmarks and the volatility may be materially different from the volatility of Illustrative Benchmarks. Reference or comparison to an Illustrative Benchmark does not imply that strategies of Enhanced Investments will be constructed in the same way as the Illustrative Benchmark or achieve returns, volatility, or other results similar to those of the Illustrative Benchmark. The S&P 500 is an unmanaged market capitalization-weighted index of 500 common stocks chosen for market size, liquidity, and industry group representation to represent U.S. equity performance.
Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.